{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:20:21Z","timestamp":1787026821298,"version":"build-2736575974"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,2,13]],"date-time":"2023-02-13T00:00:00Z","timestamp":1676246400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Autoimmune autonomic ganglionopathy (AAG) is a rare disorder characterized by autonomic failure associated with the presence of anti-ganglionic acetylcholine receptor (gAChR) antibodies; however, several studies have reported that individuals with anti-gAChR antibodies present with central nervous system (CNS) symptoms such as impaired consciousness and seizures. In the present study, we investigated whether the presence of serum anti-gAChR antibodies correlated with autonomic symptoms in patients with functional neurological symptom disorder\/conversion disorder (FNSD\/CD).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Clinical data were collected for 59 patients presenting with neurologically unexplained motor and sensory symptoms at the Department of Neurology and Geriatrics between January 2013 and October 2017 and who were ultimately diagnosed with FNSD\/CD according to the Diagnostic and Statistical Manual of Mental Disorders, 5th Edition. Correlations between serum anti-gAChR antibodies and clinical symptoms and laboratory data were analyzed. Data analysis was conducted in 2021.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Of the 59 patients with FNSD\/CD, 52 (88.1%) exhibited autonomic disturbances and 16 (27.1%) were positive for serum anti-gAChR antibodies. Cardiovascular autonomic dysfunction, including orthostatic hypotension, was significantly more prevalent (75.0 vs. 34.9%,\n                      <jats:italic>P<\/jats:italic>\n                      = 0.008), whereas involuntary movements were significantly less prevalent (31.3 vs. 69.8%,\n                      <jats:italic>P<\/jats:italic>\n                      = 0.007), among anti-gAChR antibody-positive compared with -negative patients. Anti-gAChR antibody serostatus did not correlate significantly with the frequency of other autonomic, sensory, or motor symptoms analyzed.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>An autoimmune mechanism mediated by anti-gAChR antibodies may be involved in disease etiology in a subgroup of FNSD\/CD patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fneur.2023.1137958","type":"journal-article","created":{"date-parts":[[2023,2,12]],"date-time":"2023-02-12T23:44:20Z","timestamp":1676245460000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Anti-ganglionic acetylcholine receptor antibodies in functional neurological symptom disorder\/conversion disorder"],"prefix":"10.3389","volume":"14","author":[{"given":"Ryusei","family":"Nagata","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiji","family":"Matsuura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Nozuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mika","family":"Dozono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Noguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Ando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Hiramatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Kodama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masakazu","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryuji","family":"Kubota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Munekazu","family":"Yamakuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujiro","family":"Higuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Sakiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitoshi","family":"Arata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiko","family":"Higashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teruto","family":"Hashiguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunya","family":"Nakane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Takashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,2,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1108\/RR-10-2013-0256","article-title":"Diagnostic and Statistical Manual of Mental Disorders: DSM-5 (5th edition)","volume":"28","author":"Guha","year":"","journal-title":"Ref. Rev."},{"key":"B2","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/j.neubiorev.2021.10.049","article-title":"Stress response in dissociation and conversion disorders: A systematic review","volume":"132","author":"Boulet","year":"2022","journal-title":"Neurosci Biobehav Rev."},{"key":"B3","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/S2215-0366(18)30051-8","article-title":"Stressful life events and maltreatment in conversion (functional neurological) disorder: systematic review and meta-analysis of case-control studies","volume":"5","author":"Ludwig","year":"2018","journal-title":"Lancet Psychiatry."},{"key":"B4","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1192\/bjp.bp.105.012864","article-title":"Psychiatric presentation of voltage-gated potassium channel antibody-associated encephalopathy: Case report","volume":"189","author":"Parthasarathi","year":"2006","journal-title":"Br J Psychiatry."},{"key":"B5","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1212\/01.wnl.0000278388.90370.c3","article-title":"Anti-NMDA receptor encephalitis in Japan: long-term outcome without tumor removal","volume":"70","author":"Iizuka","year":"2008","journal-title":"Neurology."},{"key":"B6","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/1471-244X-12-37","article-title":"Anti-NMDA-receptor antibody detected in encephalitis, schizophrenia, and narcolepsy with psychotic features","volume":"12","author":"Tsutsui","year":"2012","journal-title":"BMC Psychiatry."},{"key":"B7","doi-asserted-by":"publisher","first-page":"100228","DOI":"10.1016\/j.bbih.2021.100228","article-title":"Assessment of cytokines, microRNA and patient related outcome measures in conversion disorder\/functional neurological disorder (CD\/FND): The CANDO clinical feasibility study","volume":"13","author":"van der Feltz-Cornelis","year":"2021","journal-title":"Brain Behav Immun Health."},{"key":"B8","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/s00787-018-1212-2","article-title":"Blood CRP levels are elevated in children and adolescents with functional neurological symptom disorder","volume":"28","author":"Kozlowska","year":"2019","journal-title":"Eur Child Adolesc Psychiatry."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1093\/brain\/awq068","article-title":"The symptom of functional weakness: a controlled study of 107 patients","volume":"133","author":"Stone","year":"2010","journal-title":"Brain."},{"key":"B10","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1176\/appi.ajp-rj.2020.160207","article-title":"Dysautonomia-predominant functional neurological symptom disorder","volume":"16","author":"Leger","year":"2020","journal-title":"Am J Psychiat Residents' J"},{"key":"B11","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s10286-017-0425-7","article-title":"The autonomic medical history","volume":"27","author":"Goldstein","year":"2017","journal-title":"Clin Auton Res."},{"key":"B12","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.tips.2014.12.002","article-title":"Nicotinic ACh receptors as therapeutic targets in CNS disorders","volume":"36","author":"Dineley","year":"2015","journal-title":"Trends Pharmacol Sci."},{"key":"B13","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1080\/14737175.2018.1540304","article-title":"Autoimmune autonomic ganglionopathy: an update on diagnosis and treatment","volume":"18","author":"Nakane","year":"2018","journal-title":"Expert Rev Neurother."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1016\/S0306-4522(99)00160-8","article-title":"Alpha subunit composition of nicotinic acetylcholine receptors in the rat autonomic ganglia neurons as determined with subunit-specific anti-alpha(181-192) peptide antibodies","volume":"93","author":"Skok","year":"1999","journal-title":"Neuroscience."},{"key":"B15","doi-asserted-by":"publisher","first-page":"e23043","DOI":"10.7554\/eLife.23043","article-title":"Structural insights into the molecular mechanisms of myasthenia gravis and their therapeutic implications","volume":"6","author":"Noridomi","year":"2017","journal-title":"Elife"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1212\/WNL.50.6.1806","article-title":"Neuronal nicotinic ACh receptor antibody in subacute autonomic neuropathy and cancer-related syndromes","volume":"50","author":"Vernino","year":"1998","journal-title":"Neurology."},{"key":"B17","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1111\/j.1464-410X.2005.05294.x","article-title":"The role of urinary urgency and its measurement in the overactive bladder symptom syndrome: current concepts and future prospects","volume":"95","author":"Chapple","year":"2005","journal-title":"BJU Int."},{"key":"B18","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.urology.2010.06.044","article-title":"Assessment of overactive bladder symptoms: comparison of 3-day bladder diary and the overactive bladder symptoms score","volume":"77","author":"Homma","year":"2011","journal-title":"Urology."},{"key":"B19","doi-asserted-by":"publisher","first-page":"e0118312","DOI":"10.1371\/journal.pone.0118312","article-title":"Clinical features of autoimmune autonomic ganglionopathy and the detection of subunit-specific autoantibodies to the ganglionic acetylcholine receptor in Japanese patients","volume":"10","author":"Nakane","year":"2015","journal-title":"PLoS ONE."},{"key":"B20","doi-asserted-by":"publisher","first-page":"787037","DOI":"10.3389\/fnint.2021.787037","article-title":"Autonomic dysfunction in autism spectrum disorder","volume":"15","author":"Owens","year":"2021","journal-title":"Front Integr Neurosci."},{"key":"B21","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1001\/archneurol.2009.78","article-title":"Ganglionic acetylcholine receptor autoantibody: oncological, neurological, and serological accompaniments","volume":"66","author":"McKeon","year":"2009","journal-title":"Arch Neurol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"e1162","DOI":"10.1212\/NXI.0000000000001162","article-title":"Novel Cell-Based Assay for Alpha-3 Nicotinic Receptor Antibodies Detects Antibodies Exclusively in Autoimmune Autonomic Ganglionopathy","volume":"9","author":"Karagiorgou","year":"2022","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"B23","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1056\/NEJM200009213431204","article-title":"Autoantibodies to ganglionic acetylcholine receptors in autoimmune autonomic neuropathies","volume":"343","author":"Vernino","year":"2000","journal-title":"N Engl J Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"102403","DOI":"10.1016\/j.jaut.2020.102403","article-title":"A comprehensive analysis of the clinical characteristics and laboratory features in 179 patients with autoimmune autonomic ganglionopathy","volume":"108","author":"Nakane","year":"2020","journal-title":"J Autoimmun."},{"key":"B25","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.autneu.2008.10.016","article-title":"Autoimmune autonomic ganglionopathy with late-onset encephalopathy","volume":"146","author":"Baker","year":"2009","journal-title":"Auton Neurosci."},{"key":"B26","doi-asserted-by":"publisher","first-page":"3862","DOI":"10.1158\/1078-0432.CCR-14-0652","article-title":"Neural autoantibody clusters aid diagnosis of cancer","volume":"20","author":"Horta","year":"2014","journal-title":"Clin Cancer Res."},{"key":"B27","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.autneu.2008.12.002","article-title":"Autoimmune autonomic ganglionopathy with Sj\u00f6gren's syndrome: significance of ganglionic acetylcholine receptor antibody and therapeutic approach","volume":"146","author":"Kondo","year":"2009","journal-title":"Auton Neurosci."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1212\/01.wnl.0000191566.86977.04","article-title":"Alpha7-acetylcholine receptor antibodies in two patients with Rasmussen encephalitis","volume":"65","author":"Watson","year":"2005","journal-title":"Neurology."},{"key":"B29","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1002\/mus.24559","article-title":"Clinical experience of seropositive ganglionic acetylcholine receptor antibody in a tertiary neurology referral center","volume":"52","author":"Li","year":"2015","journal-title":"Muscle Nerve."},{"key":"B30","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1136\/jnnp-2016-314707","article-title":"Extra-autonomic manifestations in autoimmune autonomic ganglionopathy: A Japanese survey","volume":"88","author":"Nakane","year":"2017","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B31","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.pharmthera.2012.08.012","article-title":"Nicotinic acetylcholine receptors: from basic science to therapeutics","volume":"137","author":"Hurst","year":"2013","journal-title":"Pharmacol Ther."},{"key":"B32","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1016\/S0025-6196(12)62272-1","article-title":"The central autonomic network: functional organization, dysfunction, and perspective","volume":"68","author":"Benarroch","year":"1993","journal-title":"Mayo Clin Proc."},{"key":"B33","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/j.neubiorev.2011.11.009","article-title":"A meta-analysis of heart rate variability and neuroimaging studies: implications for heart rate variability as a marker of stress and health","volume":"36","author":"Thayer","year":"2012","journal-title":"Neurosci Biobehav Rev."},{"key":"B34","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3389\/fnins.2015.00034","article-title":"Structural brain abnormalities in postural tachycardia syndrome: A VBM-DARTEL study","volume":"9","author":"Umeda","year":"2015","journal-title":"Front Neurosci."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2023.1137958\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,12]],"date-time":"2023-02-12T23:44:22Z","timestamp":1676245462000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2023.1137958\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,13]]},"references-count":34,"alternative-id":["10.3389\/fneur.2023.1137958"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2023.1137958","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,13]]},"article-number":"1137958"}}